comparemela.com

Latest Breaking News On - Claudia ulbrich - Page 1 : comparemela.com

The heart is back, says Cardior CEO, as Novo s $1B deal boosts field

BioPharma

Claudia ulbrichThomas thumDrug administrationCardior pharmaceuticalsGermany hannover medical schoolNovo nordiskHannover medical schoolProfessor thomas thumAcross novo

Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease

Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved. Cardior is a leader in the discovery and development of therapies that target RNA as a means to prevent, repair and reverse diseases of the heart. The company’s therapeutic approach targets distinctive non-coding RNAs as a platform for addressing root causes of cardiac dysfunctions with an aim to achieve lasting patient impact.

Claudia ulbrichMartin holst langeNovo nordiskDevelopment at novo nordiskCardior pharmaceuticalsEuropean heart journal

Novo nabs Cardior in €1B deal, gaining phase II-stage miRNA drug

In what co-founder and CEO Claudia Ulbrich called the “right decision with right partner at the right point in time,” Cardior Pharmaceuticals GmbH agreed to an acquisition by Novo Nordisk A/S in a deal worth up to €1.025 billion (US$1.1 billion) that puts a potentially disease-modifying heart failure candidate in the hands of a big pharma player in the midst of establishing its presence in cardiovascular disease.

Claudia ulbrichNovo nordiskCardior pharmaceuticals gmbPharmaceuticals gmbhNovo nordiska sCardior pharmaceuticals gmbhCdr 132lHeart diseaseMir 132Deals andm amp aMir 132 inhibitorNoncoding rnaHeart failureCardiac hypertrophy

Novo Nordisk to acquire cardiovascular disease specialist Cardior in deal worth over €1bn

Novo Nordisk to acquire cardiovascular disease specialist Cardior in deal worth over €1bn
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Claudia ulbrichMartin holst langeNovo nordiskCardior pharmaceuticalsHolst lange

Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease

Bagsværd, Denmark, and Hannover, Germany, 25 March, 2024 – Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros,.

Claudia ulbrichFrederik taylor pitterSina meyerJacob martin wiborgAmbre james brownDaniel muusmann bohsenDavid heiberg landstedMartin holst langeNovo nordiskCardior pharmaceuticalsDevelopment at novo nordiskGlobal public health burden of heart failureTrophic communicationsEuropean heartJoseph rootHeart journal

vimarsana © 2020. All Rights Reserved.